CASP8 Chromosome 2
Caspase 8
Upload your DNA to see your personal genotypes for variants in CASP8.
What This Gene Does
This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunits. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined. [provided by RefSeq, Jul 2008]
Gene Info
Gene Group
"Caspases|Death effector domain containing|Ripoptosome|Death inducing signaling complex"
Locus Type
gene with protein product
Location
2q33.1
Ensembl
ENSG00000064012
Associated Conditions (5)
Autoimmune lymphoproliferative syndrome type 2B
Inborn genetic diseases
Lung cancer
Hepatocellular carcinoma
protection against
Key Variants
RS146286958
Conflicting classifications of pathogenicity
Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B
Health Risk
RS199934929
Conflicting classifications of pathogenicity
Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B
Health Risk
RS372378810
Conflicting classifications of pathogenicity
Autoimmune lymphoproliferative syndrome type 2B, Inborn genetic diseases, Autoimmune lymphoproliferative syndrome type 2B
Health Risk
RS375465590
Conflicting classifications of pathogenicity
Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B
Health Risk
RS549753655
Conflicting classifications of pathogenicity
Autoimmune lymphoproliferative syndrome type 2B, Inborn genetic diseases, Autoimmune lymphoproliferative syndrome type 2B
Health Risk
RS573893736
Conflicting classifications of pathogenicity
Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B
Health Risk
RS759581547
Conflicting classifications of pathogenicity
Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B
Health Risk
RS768360449
Conflicting classifications of pathogenicity
Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B
Health Risk
RS774015258
Conflicting classifications of pathogenicity
Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B
Health Risk
RS776712453
Conflicting classifications of pathogenicity
Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B
Health Risk
RS777463099
Conflicting classifications of pathogenicity
Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B
Health Risk
RS1559356254
Likely pathogenic
Lung cancer, Lung cancer
Health Risk
All Variants (31)
| RSID | Category | Clinical Significance | Conditions |
|---|---|---|---|
| RS146286958 | Health Risk | Conflicting classifications of pathogenicity | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS199934929 | Health Risk | Conflicting classifications of pathogenicity | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS372378810 | Health Risk | Conflicting classifications of pathogenicity | Autoimmune lymphoproliferative syndrome type 2B, Inborn genetic diseases, Autoimmune lymphoproliferative syndrome type 2B |
| RS375465590 | Health Risk | Conflicting classifications of pathogenicity | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS549753655 | Health Risk | Conflicting classifications of pathogenicity | Autoimmune lymphoproliferative syndrome type 2B, Inborn genetic diseases, Autoimmune lymphoproliferative syndrome type 2B |
| RS573893736 | Health Risk | Conflicting classifications of pathogenicity | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS759581547 | Health Risk | Conflicting classifications of pathogenicity | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS768360449 | Health Risk | Conflicting classifications of pathogenicity | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS774015258 | Health Risk | Conflicting classifications of pathogenicity | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS776712453 | Health Risk | Conflicting classifications of pathogenicity | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS777463099 | Health Risk | Conflicting classifications of pathogenicity | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS1559356254 | Health Risk | Likely pathogenic | Lung cancer, Lung cancer |
| RS1948252170 | Health Risk | Likely pathogenic | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS373232880 | Health Risk | Likely pathogenic | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS1368296717 | Health Risk | Pathogenic | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS143410219 | Health Risk | Pathogenic | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS1457092267 | Health Risk | Pathogenic | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS1559374786 | Health Risk | Pathogenic | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS2470003978 | Health Risk | Pathogenic | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS2470005907 | Health Risk | Pathogenic | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS2470081765 | Health Risk | Pathogenic | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS2470084250 | Health Risk | Pathogenic | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS587776665 | Health Risk | Pathogenic | Hepatocellular carcinoma, Hepatocellular carcinoma |
| RS747862347 | Health Risk | Pathogenic | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS758051022 | Health Risk | Pathogenic | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS760132764 | Health Risk | Pathogenic | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS762135470 | Health Risk | Pathogenic | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS765672355 | Health Risk | Pathogenic | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS777784105 | Health Risk | Pathogenic | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS17860424 | Health Risk | Pathogenic/Likely pathogenic | Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS3834129 | Protective | protective | Lung cancer, protection against, Lung cancer |